MEIJI SEIKA PHARMATECH CO LIMITED — Glimepiride Importer Profile
Pharmaceutical Importer · #4 buyer for Glimepiride · $1.4M import value · 32 shipments · JAPAN · DGFT Verified
MEIJI SEIKA PHARMATECH CO LIMITED is the #4 importer of Glimepiride from India with $1.4M in import value and 32 verified shipments. MEIJI SEIKA PHARMATECH CO LIMITED holds a 0.9% market share in Glimepiride imports based in JAPAN. The company sources from 1 verified supplier across 21 formulations shipped to 1 country. Overall, MEIJI SEIKA PHARMATECH CO LIMITED imports 4 pharmaceutical products worth $5.1M across 3 therapeutic categories.
MEIJI SEIKA PHARMATECH CO LIMITED — Glimepiride Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Glimepiride to MEIJI SEIKA PHARMATECH CO LIMITED?
Verified from 32 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MEDREICH LIMITED | $1.4M | 32 | 100.0% |
MEIJI SEIKA PHARMATECH CO LIMITED sources Glimepiride from 1 verified Indian supplier based on 32 customs records. The primary supplier is MEDREICH LIMITED accounting for 100.0% of imports.
How Does MEIJI SEIKA PHARMATECH CO LIMITED Compare to Nearest Glimepiride Importers?
Buyers ranked immediately above and below #4 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | EVERSANA LIFE SCIENCE SERVICES LLC | UNITED STATES | $905.2K | 25 | $36.2K |
| 6 | APL SWIFT SERVICES (MALTA) LTD., | MALTA | $780.5K | 109 | $7.2K |
| 4 | MEIJI SEIKA PHARMATECH CO LIMITED ★ | JAPAN | $750.0K | 15 | $50.0K |
| 7 | AMERISOURCE HEALTH SERVICES | UNITED STATES | $704.6K | 38 | $18.5K |
| 3 | MEIJI SEIKA PHARMATECH CO., LTD | JAPAN | $650.0K | 13 | $50.0K |
MEIJI SEIKA PHARMATECH CO LIMITED ranks #4 among 535 Glimepiride importers from India. Average shipment value of $50.0K compared to the market average of $17.0K. The closest competitors by value are EVERSANA LIFE SCIENCE SERVICES LLC and APL SWIFT SERVICES (MALTA) LTD.,.
Where Does MEIJI SEIKA PHARMATECH CO LIMITED Import Glimepiride To?
Destination countries from 32 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| JAPAN | $1.4M | 32 | 100.0% |
MEIJI SEIKA PHARMATECH CO LIMITED imports Glimepiride to 1 country. The primary destination is JAPAN receiving 100.0% of shipments worth $1.4M.
What Glimepiride Formulations Does MEIJI SEIKA PHARMATECH CO LIMITED Import?
| Formulation | Value | Shipments |
|---|---|---|
| GLIMEPIRIDE 1MG TABLETS PO NO.MM-158-22 | $293.3K | 8 |
| GLIMEPIRIDE 0.5MG TABLETS PO NO.MM-158- | $249.8K | 5 |
| GLIMEPIRIDE 0.5MG TABLETS, PO NO.MM-156, | $50.0K | 1 |
| GLIMEPIRIDE 1MG TABLETS, PO NO.MM-156, P | $50.0K | 1 |
| GLIMEPIRIDE 1MG TABLETS - MM-160 DTD 22.02.2023, PACK SIZE:50000S, QTY:122.333 | $50.0K | 1 |
| GLIMEPIRIDE 0.5MG TABLETS - MM-163 DTD29.05.2023 PACK SIZE:100000S QTY:60.070 | $50.0K | 1 |
| GLIMEPIRIDE 1MG TABLETS, P.O NO. MM-164DTD 23.06.2023, PACK SIZE:50000S, QTY:121.979 | $50.0K | 1 |
| GLIMEPIRIDE 0.5MG TABLETS P.O NO. MM-168 DTD 20.09.2023 PACK SIZE:100000S QTY:28.772KGS | $50.0K | 1 |
| GLIMEPIRIDE 1MG TABLETS P.O NO. MM-167DTD 30.08.2023 PACK SIZE:50000S QTY:60.581KGS | $50.0K | 1 |
| GLIMEPIRIDE 1MG TABLETS , PACK SIZE:50000S , QTY:59.584 | $50.0K | 1 |
MEIJI SEIKA PHARMATECH CO LIMITED imports 21 distinct Glimepiride formulations from India. The top formulation is GLIMEPIRIDE 1MG TABLETS PO NO.MM-158-22 with 8 shipments worth $293.3K.
Regulatory Requirements: Importing Glimepiride into Japan
What MEIJI SEIKA PHARMATECH CO LIMITED and other importers must comply with to import Glimepiride from India
Regulatory Authority
Pharmaceuticals and Medical Devices Agency (PMDA)
Approval Process for Generic Glimepiride
Generic Drug Application under Japan Pharmaceutical Affairs Act. Requires dissolution and bioequivalence studies per PMDA guidelines. Japanese data bridging often required.
Typical timeline: 12–24 months
GMP Requirements
Japanese GMP (J-GMP) compliance; PMDA on-site inspection of manufacturing facility
Import Licence & Documentation
Marketing Authorization Holder (MAH) must be a Japanese entity; Foreign Manufacturer Registration (Accreditation) required
Labeling & Packaging
Japanese language labeling mandatory; Japanese Pharmacopoeia compliance
Note: Japan requires Yen-denominated pricing approval (NHI drug price listing). Stability data under ICH Zone IVb conditions.
Regulatory information is provided for general reference based on publicly available PMDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with PMDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Glimepiride from India and How Much Does MEIJI SEIKA PHARMATECH CO LIMITED Import?
India exported $9.1M worth of Glimepiride through 3,159 shipments from 242 suppliers to 94 countries, serving 535 buyers globally. MEIJI SEIKA PHARMATECH CO LIMITED imports $1.4M of this total, accounting for 0.9% of India's Glimepiride exports with 32 shipments from JAPAN. This is verified from 32 customs shipment records covering 21 distinct formulations.
What Is the Average Order Value for MEIJI SEIKA PHARMATECH CO LIMITED's Glimepiride Imports?
MEIJI SEIKA PHARMATECH CO LIMITED's average Glimepiride order value is $44.9K per consignment, based on 32 shipments totaling $1.4M. MEIJI SEIKA PHARMATECH CO LIMITED is based in JAPAN and ranks #4 among all Glimepiride importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Glimepiride to MEIJI SEIKA PHARMATECH CO LIMITED?
MEIJI SEIKA PHARMATECH CO LIMITED sources Glimepiride from 1 verified Indian supplier: MEDREICH LIMITED ($1.4M, 100.0%). This is based on 32 customs records.
How Does MEIJI SEIKA PHARMATECH CO LIMITED Compare to Other Glimepiride Importers?
MEIJI SEIKA PHARMATECH CO LIMITED ranks #4 among 535 Glimepiride importers from India with a 0.9% market share. The top 3 importers are EVERSANA LIFE SCIENCE SERVICES, LLC ($1.3M), EVERSANA LIFE SCIENCE SERVICES LLC ($905.2K), APL SWIFT SERVICES (MALTA) LTD., ($780.5K). MEIJI SEIKA PHARMATECH CO LIMITED processed 32 shipments from JAPAN.
About MEIJI SEIKA PHARMATECH CO LIMITED
MEIJI SEIKA PHARMATECH CO LIMITED imports 4 products worth $5.1M. Beyond Glimepiride, top products include Pravastatin, Amlodipine, Famotidine. View the complete MEIJI SEIKA PHARMATECH CO LIMITED profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Glimepiride — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Glimepiride shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: MEIJI SEIKA PHARMATECH CO LIMITED matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as MEIJI SEIKA PHARMATECH CO LIMITED's capped import value divided by total capped export value for Glimepiride across all Indian exporters.
- 5.Verified Records: This page is backed by 32 individual customs records matching MEIJI SEIKA PHARMATECH CO LIMITED importing Glimepiride, covering 21 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 94+ countries, 535+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Glimepiride Import Data for MEIJI SEIKA PHARMATECH CO LIMITED
Access order-level details, pricing data, supplier connections, and competitive analysis for MEIJI SEIKA PHARMATECH CO LIMITED's Glimepiride imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MEIJI SEIKA PHARMATECH CO LIMITED
Full Company Profile →
4 products · $5.1M total trade · 3 categories
MEIJI SEIKA PHARMATECH CO LIMITED × Glimepiride
Verified from customs records
Company Overview
Top Products by MEIJI SEIKA PHARMATECH CO LIMITED
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for MEIJI SEIKA PHARMATECH CO LIMITED.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Glimepiride. For current order-level data, contact TransData Nexus.